Buys
Open market- Shares
- +25,000
- Avg price
- $0.7876
- Total value
- +$19,690
Mark Voll - Chief Financial Officer at RenovoRx, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- RNXT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Mark Voll in RenovoRx, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +25,000
- Share %
- 100%
- Total value
- +$19,690
Reported holdings for Mark Voll in RenovoRx, Inc.
Form 4 holding
Chief Financial Officer
RenovoRx, Inc.
- Security class
- Common Stock
- Shares / value
- 142,380
- Estimated value
- $112,138
- Report date
- 19 May 2026
- Price
- $0.7876
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
RenovoRx, Inc.
- Security class
- Common Stock
- Shares / value
- 97,200
- Estimated value
- $98,172
- Report date
- 19 May 2026
- Price
- $1.01
- Ownership
- Voll Family Trust DTD 6/23/2010 Mark Voll TTEE
Form 4 holding
Chief Financial Officer
RenovoRx, Inc.
- Security class
- Warrants
- Shares / value
- 48,600
- Estimated value
- Report date
- 20 Mar 2026
- Price
- Ownership
- Voll Family Trust DTD 6/23/2010 Mark Voll TTEE
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark Voll in RenovoRx, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.